688575.SH
亚辉龙
SSE · Healthcare · Medical - Specialties · CN
CNY 9.20
−3.66%Year over year
Reported trailing growth
- Revenue
- -10.4%
- EBITDA
- —
- EBIT
- -48.4%
- EPS
- -86.2%
- Free cash flow
- +541.3%
- Operating cash flow
- +8.6%
Forward estimates
Based on analyst estimates
- Revenue
- +4.7%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -23.1%
- EBITDA
- -33.0%
- EBIT
- -54.7%
- Net income
- -71.5%
- EPS
- -71.8%
- Free cash flow
- -60.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026